nodes	percent_of_prediction	percent_of_DWPC	metapath
Icatibant—BDKRB2—nephron tubule—systemic lupus erythematosus	0.0462	0.0947	CbGeAlD
Icatibant—ANPEP—Metabolism of Angiotensinogen to Angiotensins—ACE—systemic lupus erythematosus	0.0449	0.099	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.0439	0.0967	CbGpPWpGaD
Icatibant—BDKRB2—kidney—systemic lupus erythematosus	0.0406	0.0832	CbGeAlD
Icatibant—BDKRB2—cortex of kidney—systemic lupus erythematosus	0.0395	0.081	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—ACE—systemic lupus erythematosus	0.0392	0.0862	CbGpPWpGaD
Icatibant—BDKRB2—tendon—systemic lupus erythematosus	0.0328	0.0672	CbGeAlD
Icatibant—ANPEP—connective tissue—systemic lupus erythematosus	0.0297	0.0609	CbGeAlD
Icatibant—ANPEP—nephron tubule—systemic lupus erythematosus	0.0288	0.059	CbGeAlD
Icatibant—BDKRB2—lung—systemic lupus erythematosus	0.0288	0.0589	CbGeAlD
Icatibant—ANPEP—skin of body—systemic lupus erythematosus	0.0268	0.055	CbGeAlD
Icatibant—BDKRB2—nervous system—systemic lupus erythematosus	0.0266	0.0546	CbGeAlD
Icatibant—BDKRB2—central nervous system—systemic lupus erythematosus	0.0256	0.0526	CbGeAlD
Icatibant—ANPEP—kidney—systemic lupus erythematosus	0.0253	0.0519	CbGeAlD
Icatibant—ANPEP—cortex of kidney—systemic lupus erythematosus	0.0246	0.0505	CbGeAlD
Icatibant—ANPEP—lymphoid tissue—systemic lupus erythematosus	0.0217	0.0446	CbGeAlD
Icatibant—ANPEP—tendon—systemic lupus erythematosus	0.0204	0.0419	CbGeAlD
Icatibant—ANPEP—bone marrow—systemic lupus erythematosus	0.0198	0.0406	CbGeAlD
Icatibant—BDKRB2—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.0182	0.0401	CbGpPWpGaD
Icatibant—ANPEP—lung—systemic lupus erythematosus	0.0179	0.0368	CbGeAlD
Icatibant—ANPEP—nervous system—systemic lupus erythematosus	0.0166	0.034	CbGeAlD
Icatibant—ANPEP—central nervous system—systemic lupus erythematosus	0.016	0.0328	CbGeAlD
Icatibant—BDKRB2—Direct p53 effectors—PRDM1—systemic lupus erythematosus	0.0157	0.0346	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	0.0145	0.0319	CbGpPWpGaD
Icatibant—BDKRB2—Validated transcriptional targets of deltaNp63 isoforms—VDR—systemic lupus erythematosus	0.0135	0.0297	CbGpPWpGaD
Icatibant—BDKRB2—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.012	0.0265	CbGpPWpGaD
Icatibant—ANPEP—Peptide hormone metabolism—ACE—systemic lupus erythematosus	0.0118	0.026	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—IRF5—systemic lupus erythematosus	0.00972	0.0214	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—CSK—systemic lupus erythematosus	0.0094	0.0207	CbGpPWpGaD
Icatibant—BDKRB2—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.00824	0.0182	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—GADD45A—systemic lupus erythematosus	0.00752	0.0166	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.00709	0.0156	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00658	0.0145	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.00566	0.0125	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00564	0.0124	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—VDR—systemic lupus erythematosus	0.00563	0.0124	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.00534	0.0118	CbGpPWpGaD
Icatibant—ANPEP—Cardiac Progenitor Differentiation—TGFB1—systemic lupus erythematosus	0.0053	0.0117	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CD4—systemic lupus erythematosus	0.00511	0.0113	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—PTGS2—systemic lupus erythematosus	0.00508	0.0112	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—FAS—systemic lupus erythematosus	0.00491	0.0108	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	0.00481	0.0106	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.00478	0.0105	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.00477	0.0105	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.0045	0.00991	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	0.00444	0.00977	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.00429	0.00945	CbGpPWpGaD
Icatibant—ANPEP—C-MYB transcription factor network—EP300—systemic lupus erythematosus	0.00422	0.0093	CbGpPWpGaD
Icatibant—BDKRB2—Regulation of Actin Cytoskeleton—F2—systemic lupus erythematosus	0.00404	0.0089	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00388	0.00854	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.00379	0.00835	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.00379	0.00834	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.00371	0.00816	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.00337	0.00742	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00333	0.00732	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.00327	0.0072	CbGpPWpGaD
Icatibant—BDKRB2—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.0032	0.00704	CbGpPWpGaD
Icatibant—BDKRB2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.00303	0.00668	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.00301	0.00663	CbGpPWpGaD
Icatibant—BDKRB2—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00296	0.00653	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00289	0.00636	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—CDKN1A—systemic lupus erythematosus	0.0027	0.00594	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.0026	0.00573	CbGpPWpGaD
Icatibant—BDKRB2—Direct p53 effectors—EP300—systemic lupus erythematosus	0.00257	0.00565	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00254	0.0056	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.00244	0.00537	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00243	0.00534	CbGpPWpGaD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00223	0.00491	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—ACE—systemic lupus erythematosus	0.00223	0.00491	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.0022	0.00485	CbGpPWpGaD
Icatibant—Injection site reaction—Mycophenolate mofetil—systemic lupus erythematosus	0.00217	0.0373	CcSEcCtD
Icatibant—BDKRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00199	0.00438	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00198	0.00436	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—C3—systemic lupus erythematosus	0.00193	0.00426	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—F2—systemic lupus erythematosus	0.0017	0.00374	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00163	0.0036	CbGpPWpGaD
Icatibant—Body temperature increased—Dapsone—systemic lupus erythematosus	0.00153	0.0263	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00152	0.00335	CbGpPWpGaD
Icatibant—BDKRB2—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.00151	0.00333	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.00148	0.00326	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.00138	0.00304	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—TLR9—systemic lupus erythematosus	0.00134	0.00296	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—F2—systemic lupus erythematosus	0.00131	0.00288	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.0013	0.00287	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.00123	0.00271	CbGpPWpGaD
Icatibant—Headache—Dapsone—systemic lupus erythematosus	0.00121	0.0209	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CSK—systemic lupus erythematosus	0.0012	0.00264	CbGpPWpGaD
Icatibant—BDKRB2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	0.00119	0.00263	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.00118	0.0026	CbGpPWpGaD
Icatibant—ANPEP—Metabolism of proteins—CCL2—systemic lupus erythematosus	0.00116	0.00256	CbGpPWpGaD
Icatibant—Nausea—Dapsone—systemic lupus erythematosus	0.00115	0.0198	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.00112	0.00246	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.0011	0.00243	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NCF2—systemic lupus erythematosus	0.0011	0.00241	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00109	0.00241	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—LYN—systemic lupus erythematosus	0.00109	0.0024	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00107	0.00236	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00107	0.00235	CbGpPWpGaD
Icatibant—Anaphylactic shock—Leflunomide—systemic lupus erythematosus	0.00103	0.0178	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.00102	0.00224	CbGpPWpGaD
Icatibant—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.00101	0.0175	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.001	0.00221	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—C3—systemic lupus erythematosus	0.000993	0.00219	CbGpPWpGaD
Icatibant—BDKRB2—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00096	0.00211	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000876	0.00193	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—F2—systemic lupus erythematosus	0.000872	0.00192	CbGpPWpGaD
Icatibant—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000866	0.0149	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—JUNB—systemic lupus erythematosus	0.00086	0.00189	CbGpPWpGaD
Icatibant—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000818	0.0141	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000817	0.0018	CbGpPWpGaD
Icatibant—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000807	0.0139	CcSEcCtD
Icatibant—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000799	0.0137	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—PRL—systemic lupus erythematosus	0.000792	0.00174	CbGpPWpGaD
Icatibant—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000783	0.0135	CcSEcCtD
Icatibant—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000779	0.0134	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000777	0.00171	CbGpPWpGaD
Icatibant—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000764	0.0131	CcSEcCtD
Icatibant—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000762	0.0131	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000727	0.0125	CcSEcCtD
Icatibant—Dizziness—Azathioprine—systemic lupus erythematosus	0.000725	0.0125	CcSEcCtD
Icatibant—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.00071	0.0122	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000706	0.00155	CbGpPWpGaD
Icatibant—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000696	0.012	CcSEcCtD
Icatibant—Rash—Azathioprine—systemic lupus erythematosus	0.000691	0.0119	CcSEcCtD
Icatibant—Dermatitis—Azathioprine—systemic lupus erythematosus	0.00069	0.0119	CcSEcCtD
Icatibant—Headache—Azathioprine—systemic lupus erythematosus	0.000687	0.0118	CcSEcCtD
Icatibant—Dizziness—Leflunomide—systemic lupus erythematosus	0.000684	0.0118	CcSEcCtD
Icatibant—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000668	0.0115	CcSEcCtD
Icatibant—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000667	0.0115	CcSEcCtD
Icatibant—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000654	0.0112	CcSEcCtD
Icatibant—Rash—Leflunomide—systemic lupus erythematosus	0.000653	0.0112	CcSEcCtD
Icatibant—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000652	0.0112	CcSEcCtD
Icatibant—Nausea—Azathioprine—systemic lupus erythematosus	0.000651	0.0112	CcSEcCtD
Icatibant—Headache—Leflunomide—systemic lupus erythematosus	0.000648	0.0111	CcSEcCtD
Icatibant—BDKRB2—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000647	0.00142	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000633	0.0014	CbGpPWpGaD
Icatibant—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000631	0.0109	CcSEcCtD
Icatibant—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000616	0.0106	CcSEcCtD
Icatibant—Nausea—Leflunomide—systemic lupus erythematosus	0.000615	0.0106	CcSEcCtD
Icatibant—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000606	0.0104	CcSEcCtD
Icatibant—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000606	0.0104	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCR5—systemic lupus erythematosus	0.0006	0.00132	CbGpPWpGaD
Icatibant—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000595	0.0102	CcSEcCtD
Icatibant—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000595	0.0102	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000592	0.0013	CbGpPWpGaD
Icatibant—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000588	0.0101	CcSEcCtD
Icatibant—BDKRB2—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000587	0.00129	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—C3—systemic lupus erythematosus	0.000587	0.00129	CbGpPWpGaD
Icatibant—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000574	0.00987	CcSEcCtD
Icatibant—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000561	0.00965	CcSEcCtD
Icatibant—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000535	0.00921	CcSEcCtD
Icatibant—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000528	0.00909	CcSEcCtD
Icatibant—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000528	0.00908	CcSEcCtD
Icatibant—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000528	0.00908	CcSEcCtD
Icatibant—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000523	0.00899	CcSEcCtD
Icatibant—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000518	0.00891	CcSEcCtD
Icatibant—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000515	0.00886	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—F2—systemic lupus erythematosus	0.000515	0.00113	CbGpPWpGaD
Icatibant—Rash—Cyclosporine—systemic lupus erythematosus	0.000504	0.00866	CcSEcCtD
Icatibant—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000503	0.00865	CcSEcCtD
Icatibant—Headache—Cyclosporine—systemic lupus erythematosus	0.0005	0.0086	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CD80—systemic lupus erythematosus	0.000494	0.00109	CbGpPWpGaD
Icatibant—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000492	0.00847	CcSEcCtD
Icatibant—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000491	0.00845	CcSEcCtD
Icatibant—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000491	0.00845	CcSEcCtD
Icatibant—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000491	0.00844	CcSEcCtD
Icatibant—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000488	0.00839	CcSEcCtD
Icatibant—Dizziness—Prednisolone—systemic lupus erythematosus	0.000481	0.00827	CcSEcCtD
Icatibant—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000479	0.00824	CcSEcCtD
Icatibant—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000479	0.00824	CcSEcCtD
Icatibant—Nausea—Cyclosporine—systemic lupus erythematosus	0.000474	0.00816	CcSEcCtD
Icatibant—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000469	0.00807	CcSEcCtD
Icatibant—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000463	0.00796	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000459	0.00101	CbGpPWpGaD
Icatibant—Rash—Prednisolone—systemic lupus erythematosus	0.000458	0.00788	CcSEcCtD
Icatibant—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000458	0.00787	CcSEcCtD
Icatibant—Headache—Prednisolone—systemic lupus erythematosus	0.000455	0.00783	CcSEcCtD
Icatibant—Rash—Hydrocortisone—systemic lupus erythematosus	0.000448	0.0077	CcSEcCtD
Icatibant—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000447	0.00769	CcSEcCtD
Icatibant—Headache—Hydrocortisone—systemic lupus erythematosus	0.000445	0.00765	CcSEcCtD
Icatibant—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000442	0.0076	CcSEcCtD
Icatibant—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000441	0.00759	CcSEcCtD
Icatibant—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000441	0.00758	CcSEcCtD
Icatibant—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000433	0.00744	CcSEcCtD
Icatibant—Nausea—Prednisolone—systemic lupus erythematosus	0.000432	0.00742	CcSEcCtD
Icatibant—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000422	0.00725	CcSEcCtD
Icatibant—Rash—Triamcinolone—systemic lupus erythematosus	0.000421	0.00725	CcSEcCtD
Icatibant—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000421	0.00724	CcSEcCtD
Icatibant—Rash—Methylprednisolone—systemic lupus erythematosus	0.00042	0.00723	CcSEcCtD
Icatibant—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00042	0.00722	CcSEcCtD
Icatibant—Headache—Triamcinolone—systemic lupus erythematosus	0.000419	0.0072	CcSEcCtD
Icatibant—Headache—Methylprednisolone—systemic lupus erythematosus	0.000418	0.00718	CcSEcCtD
Icatibant—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000418	0.00718	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000417	0.000918	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000409	0.000901	CbGpPWpGaD
Icatibant—Dizziness—Betamethasone—systemic lupus erythematosus	0.000401	0.0069	CcSEcCtD
Icatibant—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000401	0.0069	CcSEcCtD
Icatibant—Nausea—Triamcinolone—systemic lupus erythematosus	0.000397	0.00683	CcSEcCtD
Icatibant—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000396	0.00681	CcSEcCtD
Icatibant—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000389	0.00669	CcSEcCtD
Icatibant—Rash—Dexamethasone—systemic lupus erythematosus	0.000382	0.00658	CcSEcCtD
Icatibant—Rash—Betamethasone—systemic lupus erythematosus	0.000382	0.00658	CcSEcCtD
Icatibant—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000382	0.00657	CcSEcCtD
Icatibant—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000382	0.00657	CcSEcCtD
Icatibant—Headache—Betamethasone—systemic lupus erythematosus	0.00038	0.00653	CcSEcCtD
Icatibant—Headache—Dexamethasone—systemic lupus erythematosus	0.00038	0.00653	CcSEcCtD
Icatibant—Nausea—Betamethasone—systemic lupus erythematosus	0.00036	0.00619	CcSEcCtD
Icatibant—Nausea—Dexamethasone—systemic lupus erythematosus	0.00036	0.00619	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000354	0.00078	CbGpPWpGaD
Icatibant—Dizziness—Prednisone—systemic lupus erythematosus	0.000349	0.00601	CcSEcCtD
Icatibant—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000349	0.006	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL2—systemic lupus erythematosus	0.000347	0.000764	CbGpPWpGaD
Icatibant—BDKRB2—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000345	0.00076	CbGpPWpGaD
Icatibant—Rash—Prednisone—systemic lupus erythematosus	0.000333	0.00573	CcSEcCtD
Icatibant—Dermatitis—Prednisone—systemic lupus erythematosus	0.000333	0.00572	CcSEcCtD
Icatibant—Headache—Prednisone—systemic lupus erythematosus	0.000331	0.00569	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000328	0.000723	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000327	0.00072	CbGpPWpGaD
Icatibant—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000325	0.00559	CcSEcCtD
Icatibant—Nausea—Prednisone—systemic lupus erythematosus	0.000314	0.00539	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—EP300—systemic lupus erythematosus	0.000311	0.000685	CbGpPWpGaD
Icatibant—BDKRB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000295	0.000649	CbGpPWpGaD
Icatibant—Dizziness—Methotrexate—systemic lupus erythematosus	0.000292	0.00502	CcSEcCtD
Icatibant—Rash—Methotrexate—systemic lupus erythematosus	0.000278	0.00479	CcSEcCtD
Icatibant—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000278	0.00478	CcSEcCtD
Icatibant—Headache—Methotrexate—systemic lupus erythematosus	0.000277	0.00476	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000271	0.000596	CbGpPWpGaD
Icatibant—Nausea—Methotrexate—systemic lupus erythematosus	0.000262	0.00451	CcSEcCtD
Icatibant—BDKRB2—Signaling Pathways—IL6—systemic lupus erythematosus	0.000204	0.000449	CbGpPWpGaD
